Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Blackstone Inc (BX) vs Medpace Holdings Inc (MEDP) Price & Performance

Blackstone IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Blackstone Inc vs Medpace Holdings Inc — how do they compare? Blackstone Inc trades at $145.2 (market cap $117.44B), while Medpace Holdings Inc trades at $601.56 (market cap $16.90B). The key difference: Blackstone Inc is far larger — about 6.9× Medpace Holdings Inc's market cap, and Blackstone Inc pays a 3.55% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

BXMEDP
Market Cap
$117.44B$16.90B
Sector
FinancialsTechnology
52-Week High
$188.68$620.59
52-Week Low
$102.12$393.42
Dividend Yield
3.55%
Enterprise Value
$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Blackstone Inc

Blackstone (BX) trades at $141.67, up 3.31% today, near its consensus price target of $144.00. The stock shows strong bullish technical signals and has consistently beaten earnings estimates in recent quarters. Recent news highlights strategic acquisitions, including a stake in Air Canada's Aeroplan program and a $25.3 billion Australian home loan portfolio purchase from HSBC, signaling aggressive growth and diversification.

Outlook remains positive with robust revenue growth and high profitability, though elevated valuation ratios and overbought RSI levels suggest near-term caution. Key risks include market volatility and integration challenges from recent deals. Analyst consensus is strongly bullish, supporting a favorable long-term view.

Medpace Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Blackstone Inc

Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.

Read more on BX

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP